Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report

T. J. Wang, C. P. Lin, C. M. Yang, L. L K Lin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The purpose of this article is to report the use of valgancyclovir as maintenance therapy for cytomegalovirus (CMV) retinitis in a lung transplanted patient A 30-year-old woman with underlying pulmonary lymphangioleiomyomatosis received a lung transplant 1 year ago. CMV retinitis developed 4 months later but subsided after intravenous ganciclovir treatment. Unfortunately, the CMV retinitis recurred three times in 1 year while on oral ganciclovir maintenance therapy. To treat the latest relapse, valgancyclovir 900 mg once daily was used as maintenance therapy after intravenous gancyclovir induction. With a 6-month follow-up, the fundoscopic examination revealed old atrophic scar and no active CMV retinits. The patient was able to maintain best-corrected visual acuity of 20/20 in both eyes. In conclusion, Valganciclovir may be used as maintenance therapy in CMV retinitis.

Original languageEnglish
Pages (from-to)2826-2829
Number of pages4
JournalTransplantation Proceedings
Volume36
Issue number9
DOIs
Publication statusPublished - Nov 2004
Externally publishedYes

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Valgancyclovir as maintenance therapy for cytomegalovirus retinitis in a lung transplant patient - A case report'. Together they form a unique fingerprint.

  • Cite this